Medicamen Biotech Director Sanjay Bansal Sells Equity Stake Worth Rs 1.05 Crore
Medicamen Biotech Ltd 路 Others (Uncategorized) 路 30 Sept 2026, 10:30 pm
Medicamen Biotech Director Sanjay Bansal Sells Equity Stake Worth Rs 1.05 Crore Medicamen Biotech Limited director Sanjay Bansal executed an on-market sale of 32,813 equity shares between 28th Sep'26 and 30th Sep'26 for a total value of Rs 1,05,42,440. Prior to the transaction, Bansal held 1,02,813 shares (0.76% stake), which reduced to 70,000 shares (0.51% stake) post-disposal. The company submitted the required Form C regulatory disclosure under Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, following intimation on 30th Sep'26. No derivative transactions were reported.
Original exchange filing (PDF)
More announcements from Medicamen Biotech Ltd
- Medicamen Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Financial Results - Quarter and Half year ended on September 30, 2026 路 13 Nov 2026
- MEDICAMEN BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 13 Nov 2026
- MEDICAMEN BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 13 Nov 2026
- Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the unaudited financial .... 路 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shivalik Rasayan Ltd & Growel Remedies Ltd 路 26 Oct 2026
- Outcome of the meeting of Preferential Issue Commitee of the Board of Directors of Medicamen Biotech Limited to consider and approve the allotmentb of 5,00,000 Equity Shares pursuant to .... 路 23 Oct 2026
